Further, when regrouping PCa patients according to these transcript levels, results evidenced the increased risk of progression for PCa patients with high expression for ACAT1 and OXCT1. Interestingly, higher levels of HMGCL appear to improve the PFS in patients with no elevated levels of ketolytic enzymes. Here, ACAT1 is linked to posterior cortical atrophy.